These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 1391516)

  • 1. Stability and stabilization of fluorocarbon emulsions destined for injection.
    Riess JG; Postel M
    Biomater Artif Cells Immobilization Biotechnol; 1992; 20(2-4):819-30. PubMed ID: 1391516
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of highly fluid, concentrated and stable fluorocarbon emulsions for diagnosis and therapy.
    Riess JG; Dalfors JL; Hanna GK; Klein DH; Krafft MP; Pelura TJ; Schutt EG
    Biomater Artif Cells Immobilization Biotechnol; 1992; 20(2-4):839-42. PubMed ID: 1391519
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Drop size stability assessment of fluorocarbon emulsions.
    Krafft MP; Postel M; Riess JG; Ni Y; Pelura TJ; Hanna GK; Song D
    Biomater Artif Cells Immobilization Biotechnol; 1992; 20(2-4):865-8. PubMed ID: 1391525
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fluorocarbon emulsions--the stability issue.
    Postel M; Riess JG; Weers JG
    Artif Cells Blood Substit Immobil Biotechnol; 1994; 22(4):991-1005. PubMed ID: 7849970
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Perfluoroalklylated phospholipids as surfactants and co-surfactants forinjectable fluorocarbon emulsions.
    Santaella C; Vierling P; Riess JG
    Biomater Artif Cells Immobilization Biotechnol; 1992; 20(2-4):835-7. PubMed ID: 1391518
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel fluorocarbon-based injectable oxygen-carrying formulations with long-term room-temperature storage stability.
    Riess JG; Cornelus C; Follana R; Krafft MP; Mahé AM; Postel M; Zarif L
    Adv Exp Med Biol; 1994; 345():227-34. PubMed ID: 8079712
    [No Abstract]   [Full Text] [Related]  

  • 7. Stabilization of perflubron emulsions with egg yolk phospholipid.
    Pelura TJ; Johnson CS; Tarara TE; Weers JG
    Biomater Artif Cells Immobilization Biotechnol; 1992; 20(2-4):845-8. PubMed ID: 1391521
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phospholipid vesiculated fluorocarbons--promising trend in blood substitutes.
    Gross U; Rüdiger S; Reichelt H; Draffehn J
    Biomater Artif Cells Immobilization Biotechnol; 1992; 20(2-4):831-3. PubMed ID: 1391517
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Telomeric THAM-derived perfluoroalkylated surfactants for fluorocarbon emulsions.
    Riess JG; Pavia AA; Pucci B; Zarif L
    Biomater Artif Cells Immobilization Biotechnol; 1992; 20(2-4):843-4. PubMed ID: 1391520
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design, synthesis and evaluation of fluorocarbons and surfactants for in vivo applications. New perfluoroalkylated polyhydroxylated surfactants.
    Riess JG; Arlen C; Greiner J; Le Blanc M; Manfredi A; Pace S; Varescon C; Zarif L
    Biomater Artif Cells Artif Organs; 1988; 16(1-3):421-30. PubMed ID: 3052646
    [TBL] [Abstract][Full Text] [Related]  

  • 11. On the perfluorocarbon emulsions of second generation.
    Meinert H; Fackler R; Knoblich A; Mader J; Reuter P; Röhlke W
    Biomater Artif Cells Immobilization Biotechnol; 1992; 20(2-4):805-18. PubMed ID: 1391515
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The use of semifluorinated alkanes in blood-substitutes.
    Meinert H; Knoblich A
    Biomater Artif Cells Immobilization Biotechnol; 1993; 21(5):583-95. PubMed ID: 8117848
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improved control over particle sizes and stability of concentrated fluorocarbon emulsions by using mixed fluorocarbon/hydrocarbon molecular dowels.
    Cornélus C; Krafft MP; Riess JG
    Artif Cells Blood Substit Immobil Biotechnol; 1994; 22(4):1183-91. PubMed ID: 7849921
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical potential of intravenously administered perfluorocarbons.
    Habler O; Kleen M; Messmer K
    Acta Anaesthesiol Scand Suppl; 1997; 111():256-8. PubMed ID: 9421036
    [No Abstract]   [Full Text] [Related]  

  • 15. Overview of progress in the fluorocarbon approach to in vivo oxygen delivery.
    Riess JG
    Biomater Artif Cells Immobilization Biotechnol; 1992; 20(2-4):183-202. PubMed ID: 1391434
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fluorocarbons and fluorinated amphiphiles in drug delivery and biomedical research.
    Krafft MP
    Adv Drug Deliv Rev; 2001 Apr; 47(2-3):209-28. PubMed ID: 11311993
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prolonged shelf stability and biocompatibility of a concentrated injectable fluorocarbon emulsion.
    Follana R; Klein D; Krafft MP; Long DM; Long CD; Ni Y; Riess JG; Valla A
    Biomater Artif Cells Immobilization Biotechnol; 1992; 20(2-4):1059-61. PubMed ID: 1391426
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [A new model describing the isolation of fluorocarbons from an organism: dissolution of fluorocarbons in the lipid components of blood].
    Obraztsov VV; Kabal'noĭ AS; Sklifas AN; Makarov KN
    Biofizika; 1992; 37(2):379-83. PubMed ID: 7578329
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Intravenous perfluorocarbons. Artificial oxygen carriers and their medical applications].
    Frietsch T; Lenz C; Waschke KF
    Dtsch Med Wochenschr; 2000 Apr; 125(15):465-72. PubMed ID: 10800445
    [No Abstract]   [Full Text] [Related]  

  • 20. Mixed fluorocarbon/hydrocarbon molecular dowels help protect concentrated fluorocarbon emulsions with large size droplets against coalescence.
    Cornélus C; Krafft MP; Riess JG
    Artif Cells Blood Substit Immobil Biotechnol; 1994; 22(4):1267-72. PubMed ID: 7849932
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.